申请人:Vertex Pharmaceuticals Incorporated
公开号:US20150293078A1
公开(公告)日:2015-10-15
The present invention relates to compounds useful in CFTR assays. The present invention also relates to compounds useful in monitoring CFTR activity in therapies for CFTR-mediated diseases. The present invention also provides an assay for use in measuring CFTR correction.
本发明涉及在CFTR测定中有用的化合物。本发明还涉及在治疗CFTR介导的疾病中监测CFTR活性的化合物。本发明还提供了一种用于测量CFTR修正的测定方法。